Evidence map›Paper›PMID 36128667›Full record

SynthesisThe American journal on addictions2023

A systematic review of virtual reality therapies for substance use disorders: Impact on secondary treatment outcomes.

Daria Taubin, Amy Berger, Dan Greenwald, Herbert Greenwald, Colin Burke, Dinah S Gongora, Timothy Wilens

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in The American journal on addictions, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Context features influence alcohol reward and motivation.Alcohol, clinical & experimental research · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Daria TaubinDepartment of Psychiatry, Harvard Medical School, Division of Child and Adolescent Psychiatry, YAW6A, Massachusetts General Hospital, Boston, Massachusetts, USA.
Amy BergerDepartment of Psychiatry, Harvard Medical School, Division of Child and Adolescent Psychiatry, YAW6A, Massachusetts General Hospital, Boston, Massachusetts, USA.
Dan Greenwald3D Therapy, LLC, Beverly, Massachusetts, USA.
Herbert Greenwald3D Therapy, LLC, Beverly, Massachusetts, USA.
Colin BurkeDepartment of Psychiatry, Harvard Medical School, Division of Child and Adolescent Psychiatry, YAW6A, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-8658-2632
Dinah S GongoraDepartment of Psychiatry, Harvard Medical School, Division of Child and Adolescent Psychiatry, YAW6A, Massachusetts General Hospital, Boston, Massachusetts, USA.
Timothy WilensDepartment of Psychiatry, Harvard Medical School, Division of Child and Adolescent Psychiatry, YAW6A, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-5749-8503
Harvard University · USRogers Sciences (United States) · US

Funding

AACAP Physician Scientist Program in Substance UseK12DA000357 · NIDA · AMERICAN ACADEMY-CHILD/ADOLESCENT PSYCH · PI Kevin M. Gray · 1998 to 2026
$29.1M
Does Treating Young Persons Psychopathology Prevent the Onset of Opioid and other Substance Use Disorders?UH3DA050252 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI WILENS, TIMOTHY E, YULE, AMY · 2020 to 2020
$3.0M
NIDA NIH HHS K12 DA000357NIDA NIH HHS UH3 DA050252
6 · The paper itself

Abstract

BACKGROUND AND

objectivesVirtual reality (VR) therapy may be an effective tool in treating urges and cravings in substance use disorder (SUD). Given the high co-occurrence of difficulties with mood, anxiety, and emotional dysregulation with SUD, this review sought to examine the extant literature on the efficacy of VR for SUD in improving these secondary treatment outcomes.

methodsA systematic literature review was conducted following PRISMA guidelines in PubMed, PsychInfo, and Embase. Studies were included if they utilized immersive VR, were conducted with individuals with substance use disorder/dependence/misuse, and included measures of mood, anxiety, depression, emotional dysregulation, or retention in treatment.

resultsSeven articles met our inclusion criteria. Five studies were conducted on patients using nicotine and utilized a cue-exposure intervention. VR was effective at reducing substance use and cravings in the majority of studies. Results on the efficacy of VR for improving mood, anxiety, and emotional regulation were mixed. Work examining retention in treatment was limited. DISCUSSION AND

conclusionsVR for SUD has the potential to improve mood and anxiety symptoms as well as retention in treatment for patients with SUD, particularly if the therapy targets these psychological symptoms. Future studies examining components of VR for SUD in individuals with drug use disorders, as well as examinations of targeted interventions for associated mood, emotional dysregulation, and retention in treatment, are necessary. SCIENTIFIC SIGNIFICANCE: This is the first systematic review of the impact of VR on mood, anxiety, and emotional dysregulation for individuals with substance use.

Indexed as

Substance-Related DisordersVirtual RealityVirtual Reality Exposure TherapyAnxiety DisordersHumansTreatment Outcome

Identifiers

PMID36128667
PMCPMC10557052
OpenAlexW4296708202

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.